Equities

Conmed Corp

Conmed Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)75.35
  • Today's Change-0.66 / -0.87%
  • Shares traded1.00
  • 1 Year change-29.74%
  • Beta1.4661
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments242921
Total Receivables, Net242191184
Total Inventory318332232
Prepaid expenses312924
Other current assets, total------
Total current assets616581460
Property, plant & equipment, net137133128
Goodwill, net807815618
Intangibles, net649682471
Long term investments------
Note receivable - long term------
Other long term assets807679
Total assets2,3002,2981,766
LIABILITIES
Accounts payable887358
Accrued expenses786268
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.717012
Other current liabilities, total1449259
Total current liabilities311297197
Total long term debt973985672
Total debt9741,055685
Deferred income tax616769
Minority interest------
Other liabilities, total12120443
Total liabilities1,4661,552981
SHAREHOLDERS EQUITY
Common stock0.310.310.31
Additional paid-in capital447413397
Retained earnings (accumulated deficit)453413497
Treasury stock - common(15)(23)(54)
Unrealized gain (loss)------
Other equity, total(50)(58)(54)
Total equity834746785
Total liabilities & shareholders' equity2,3002,2981,766
Total common shares outstanding313029
Treasury shares - common primary issue0.530.811.93
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.